Decibel Therapeutics (DBTX) 10-Q2023 Q1 Quarterly report

Filed: 15 May 23, 7:30am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ABR, accredited, animal, ARPA, Bank, banking, broader, certainty, charged, CHORD, CHORDTM, de, default, deterioration, doubt, effectuated, exceed, excise, explanatory, FDIC, Friday, geopolitical, inflationary, insolvency, insolvent, invoiced, IRA, macroeconomic, monthly, newborn, opposed, outpatient, overrule, paragraph, payroll, physiologic, physiological, preferential, proportion, PSU, receivership, recession, recoverability, refundable, regime, repurchased, restated, retention, routinely, satisfaction, Secretary, Signature, Silicon, Silvergate, Spain, subsidy, surrendered, SVB, swept, threshold, tying, unclear, uncollectible, unconditional, Valley

Removed: activation, affiliated, applying, approximate, began, bilateral, border, born, borrow, BVP, calculating, categorized, China, cochlea, collateralized, commandeered, commensurate, commerce, conclusion, conversion, core, curtailed, debilitating, determinable, developmental, differentiation, disrupted, distancing, diversity, durability, eliminating, elimination, enabled, environment, essential, estate, exemption, exercising, exit, expedient, expensed, expression, faced, factoring, fallen, fate, feedback, Finally, fourth, freestanding, geographic, greatest, Hedging, implicit, imposing, instrument, issuer, length, lessee, mice, minimize, mobility, modification, modifying, multicenter, nerve, observed, offshore, optimized, optional, orderly, Otonomy, outer, partnership, paused, Pharma, predicted, procuring, progenitor, progression, promote, promoter, promoting, protein, quarantine, randomized, rating, real, redirect, regenerated, regenerating, remotely, repatriated, repealing, represented, reprioritize, reprogramming, resultant, resume, resurgence, retroactively, retrospective, reverse, sensory, short, simplify, Simplifying, spatially, spiked, spread, STS, subtenant, survey, synaptic, temporally, tolerated, transcription, unobservable, unpaid, variant, vested, vestibulopathy, vision, worker, workplace

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

DBTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) is the type of information that the registrant treats as private or confidential. Double asterisks denote omissions.

Exhibit 10.3

SECOND AMENDMENT TO

LICENSE AGREEMENT NO. A19433

WHEREAS, the University of Florida Research Foundation, Inc., a not-for-profit corporation duly organized and existing under the laws of the State of Florida and having its principal office at 223 Grinter Hall, Gainesville, Florida, 32611, U.S.A. (hereinafter referred to as “UFRF”), and Decibel Therapeutics, Inc., a corporation duly organized under the laws of the State of Delaware, and having its principal office at 1325 Boylston Street, Suite 500, Boston, MA 02215 (hereinafter referred to as “Licensee”) entered into a license agreement effective October 29, 2020 (hereinafter “License Agreement”) as amended by the First Amendment effective June 13, 2022;

WHEREAS, the parties now wish to amend the License Agreement;

NOW THEREFORE, in consideration of the premises and mutual covenants contained herein the parties hereto agree as follows;

The following section of the license agreement shall be re-written to read as follows:

Section 3.3 Diligence Milestones:

Specifically milestone stated as “[**]” is hereby replaced with “[**]”; and milestone stated as “[**]” is hereby replaced with “[**]”

In consideration for entering into the Second Amendment, Decibel will pay to UFRF a one-time fee of [**] dollars ($[**]) within [**] of the last date of signature of the Second Amendment. This fee is non-refundable and is not an advance or otherwise creditable against any future payments to be paid under the License Agreement.

All other provisions of the License Agreement shall remain in full force and effect and unmodified by this Amendment.

This amendment shall be effective as of the last date of signature of this amendment and shall be referred to as the Second Amendment.


UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.		DECIBEL THERAPEUTICS, INC.

By:	/s/ Jim O’Connell	By:	/s/ Laurence Reid
	Jim O’Connell		Laurence Reid
	Vice President		Chief Executive Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.